L-tyrosine Powder
NDC Package 52951-002-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

L-tyrosine powders is a bulk ingredient utilized for pharmaceutical compounding or manufacturing. This formulation utilizes a powder delivery system. Marketed by Nippon Rika Co., Ltd., this product is identified by NDC 52951-002.

Identification & Billing

NDC Package Code
52951-002-01
Package Description
50 kg in 1 DRUM
Product Code
11-Digit Billing Format
52951000201

Clinical Specifications

Proprietary Name
L-tyrosine
Non-Proprietary Name
L-tyrosine
Substance Name
Tyrosine
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Nippon Rika Co., Ltd.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
08-01-1987
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52951-002-01 identifies a specific commercial package of 50 kg in 1 drum of L-tyrosine (UNFINISHED drug), a bulk ingredient labeled by Nippon Rika Co., Ltd.. This powder is formulated for use and contains tyrosine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nippon Rika Co., Ltd. on August 01, 1987. The current certification is valid through December 31, 2026.

How is this Nippon Rika Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52951000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52951-002-01
11-Digit CMS (5-4-2)
52951-0002-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.